Computational modeling of DLBCL predicts response to BH3-mimetics. (2023)
Attributed to:
Overcoming Ibrutinib and Venetoclax resistance in Chronic Lymphocytic Leukaemia.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41540-023-00286-5
PubMed Identifier: 37280330
Publication URI: http://europepmc.org/abstract/MED/37280330
Type: Journal Article/Review
Volume: 9
Parent Publication: NPJ systems biology and applications
Issue: 1
ISSN: 2056-7189